Olfactory Mucosal Autografts and Rehabilitation for Chronic Traumatic Spinal Cord Injury
Open Access
- 30 September 2009
- journal article
- other
- Published by SAGE Publications in Neurorehabilitation and Neural Repair
- Vol. 24 (1), 10-22
- https://doi.org/10.1177/1545968309347685
Abstract
Background/objective . Basic science advances in spinal cord injury (SCI) are leading to novel clinical approaches. The authors report a prospective, uncontrolled pilot study of the safety and outcomes of implanting olfactory mucosal autografts (OMA) in 20 patients with chronic, sensorimotor complete or motor complete SCI. Methods. Seven paraplegic and 13 tetraplegic subjects (17 men and 3 women; 19-37 years old) who sustained a traumatic SCI 18 to 189 months previously (mean = 49 months) were enrolled. Preoperative rehabilitation that emphasized lower extremity stepping using either overground walking training or a robotic weight-supported treadmill training was provided for 25 to 39 hours per week for a median of 4 months at 3 sites. No change in ASIA Impairment Scale (AIS) motor scores for the lower extremities or AIS grades of completeness was found. OMAs were transplanted into 1.3- to 4-cm lesions at C4-T12 neurological levels after partial scar removal. Therapy was continued postoperatively. Preoperative and postoperative assessments included AIS scores and classification, electromyography (EMG) of attempted voluntary contractions, somatosensory evoked potentials (SSEP), urodynamic studies with sphincter EMG, spinal cord magnetic resonance imaging (MRI), and otolaryngology and psychology evaluations. The Functional Independence Measure (FIM) and Walking Index for Spinal Cord Injury (WISCI) were obtained in 13 patients. Results. All patients survived and recovered olfaction. One patient was rehospitalized for aseptic meningitis. Minor adverse events occurred in 4 others. The mean duration of follow-up was 27.7 months (range = 12-45 months). By MRI, the lesion site was filled in all patients with no neoplastic overgrowth or syringomyelia. AIS grades improved in 11 of 20 patients, 6 (A → C), 3 (B → C), and 2 (A → B), and declined in 1 (B → A). Improvements included new voluntary EMG responses (15 patients) and SSEPs (4 patients). Scores improved in the FIM and WISCI (13/13 tested), and urodynamic responses improved in 5 patients. Conclusion. OMA is feasible, relatively safe, and possibly beneficial in people with chronic SCI when combined with postoperative rehabilitation. Future controlled trials may need to include a lengthy and intensive rehabilitation arm as a control.Keywords
This publication has 59 references indexed in Scilit:
- Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia PatientPLoS Medicine, 2009
- Progressive Staging of Pilot Studies to Improve Phase III Trials for Motor InterventionsNeurorehabilitation and Neural Repair, 2008
- Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trialBrain, 2008
- Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injuryNature Medicine, 2008
- Structural differentiation of skeletal muscle fibers in the absence of innervation in humansProceedings of the National Academy of Sciences, 2007
- Graft-Versus-Host Disease: A Surge of DevelopmentsPLoS Medicine, 2007
- Extensive Neuronal Differentiation of Human Neural Stem Cell Grafts in Adult Rat Spinal CordPLoS Medicine, 2007
- Induction of Oligodendrocytes From Adult Human Olfactory Epithelial‐Derived Progenitors by Transcription FactorsThe International Journal of Cell Cloning, 2005
- Quantitative [3H]thymidine autoradiography of neurogenesis in the olfactory epithelium of developing normal, hypothyroid and hypothyroid-rehabilitated ratsDevelopmental Brain Research, 1994
- Neurogenesis and neuron regeneration in the olfactory system of mammals. II. Degeneration and reconstitution of the olfactory sensory neurons after axotomyJournal of Neurocytology, 1979